Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Progenitor (PGEN) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (29)	2/24/1998 1:07:00 PM
From: Czechsinthemail	Respond to of 106

Steve, According to PGEN's annual report, the Mercator acquisition was based on their perceived need to develop a larger organization to compete more effectively in genomics: "Mercator Genetics, Inc., a California genomics company that had recently discovered the genetic basis for an iron overload disease affecting over a million Americans. Mercator had a strong scientific organization with close ties to the Stanford Human Genome Center. Where one company had needs the other had strengths." Baird